Fierce Pharma
MAY 15, 2024
Though Galapagos has undergone plenty of staff shakeups and strategy revamps in recent years, the company is sticking strong to the CAR-T pivot first unveiled by CEO Paul Stoffels, M.D., following | Galapagos has teamed up with the largest blood supply network in the U.S. to help establish decentralized CAR-T production on a national scale.
MedCity News
MAY 15, 2024
This year has been a messy one for virtual care companies, but that doesn’t mean that telehealth is dead, according to Eve Cunningham, Providence’s chief of virtual care and digital health. In her view, virtual care can definitely still be an important part of the care delivery model — but only if it is embedded into the greater healthcare delivery ecosystem.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
MAY 15, 2024
After recently placing a spotlight on Novo Nordisk’s "outrageous" U.S. | A new Senate HELP Committee report says GLP-1 drugs could "bankrupt our entire health care system" because of their high prices coupled with high uptake.
pharmaphorum
MAY 15, 2024
GSK has become the first founding partner of the new Fleming Initiative, which aims to tackle the rising threat of antimicrobial resistance (AMR) and is also backed by the UK government.
Fierce Pharma
MAY 15, 2024
After Eli Lilly sued several companies that were allegedly selling unauthorized versions of its tirzepatide products, the drugmaker has successfully cracked down on one of them. | Under legal pressure from Eli Lilly, a medical spa has agreed to pay an undisclosed settlement and undertake several "corrective actions," such as noting publicly that compounded versions of Lilly's tirzepatide products are not approved by the FDA.
MedCity News
MAY 15, 2024
Blackstone Life Sciences startup Uniquity Bio emerged from stealth with an in-licensed drug candidate that could treat a wide range of immunology and inflammation indications. The antibody’s target puts it in competition with drugs from AstraZeneca, Pfizer, and Sanofi. The post Blackstone Unveils Immunology Startup With $300M and a Phase 2-Ready Drug From Merck appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
MAY 15, 2024
Five home-testing devices to diagnose sleep apnoea, which can affect the health of around 2.5 million adults in the UK, have been recommended for NHS use by NICE.
Fierce Pharma
MAY 15, 2024
Two years ago, when Merck KGaA restructured, forming a new life science business, the goal was to maximize the enticing potential of its contract development and manufacturing organization (CDMO). | On Wednesday—amid largely positive news for Merck KGaA overall—the company reported a 17% decline in sales for its CDMO unit, blaming (PDF) “unfavorable project phasing” and a streamlining of the supply chain of one of its customers.
pharmaphorum
MAY 15, 2024
The FDA has approved Roche's HPV self-sampling solution that the company says can tackle unequal access to screening that can put women at risk of cervical cancer
Pharmaceutical Commerce
MAY 15, 2024
In an interview with Pharma Commerce Editor Nicholas Saraceno at LogiPharma Europe, Nick Porter, President, World Courier discusses mitigating supply chain risks, the future of artificial intelligence in pharma logistics, and more.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
MAY 15, 2024
Wisp members can now order TBD Health’s STI/STD testing kits on Wisp’s website for free delivery. The post Wisp Begins Offering Diagnostics Through Partnership With TBD Health appeared first on MedCity News.
pharmaphorum
MAY 15, 2024
Eisai and Biogen have filed a rolling biologics license application in the US for a subcutaneous formulation of Alzheimer’s disease therapy Leqembi that was delayed by the FDA on procedural grounds.
MedCity News
MAY 15, 2024
Holistic care requires proactive pursuit of health services, which more people might seek if financing options are available to manage costs. The post When It Comes to Preventive and Proactive Wellness, Accessibility Is Key appeared first on MedCity News.
pharmaphorum
MAY 15, 2024
House Oversight Committee passes BIOSECURE Act, which would restrict US companies from contracting with Chinese biotechs including WuXi AppTec, MGI and BGI
European Pharmaceutical Review
MAY 15, 2024
Research has demonstrated a cost-effective storage solution for compounded faricimab kept for a maximum of 28 days. Authors of the paper stated that it provides off-label use of the anti- vascular endothelial growth factor (VEGF)/angiopoietin-2 (Ang-2) biologic , “while maintaining safety in the treatment of patients”. Their study compared the stability, sterility, and binding affinity to VEGF and Ang-2 of faricimab.
pharmaphorum
MAY 15, 2024
AbbVie has agreed to pay $65 million on an option deal with start-up Gilgamesh Pharma, lining up rights to neuroplastogen compounds that can improve neuroplasticity - the ability of the brain to respond to changes. The two companies will work together on the development of a “next-generation” of psychiatric medicines, although – for now – the drugs themselves and the target indications are being kept under wraps. other than to say they include mood and anxiety disorders.
Pharmaceutical Technology
MAY 15, 2024
The US agency rejected the expanded use of Dynavax’s vaccine for adults on haemodialysis, citing insufficient efficacy and safety data.
pharmaphorum
MAY 15, 2024
BMS gets another FDA approval for its CD19-directed CAR-T Breyanzi, this time as a third-line or later therapy for follicular lymphoma
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Pharmaceutical Technology
MAY 15, 2024
Verismo Therapeutics announced FDA clearance for a Phase I trial of its CAR-T therapy to treat non-Hodgkin lymphoma.
pharmaphorum
MAY 15, 2024
AbbVie joins a select group of big pharma groups working on psychedelic medicines, paying $65m on an option deal with Gilgamesh Pharma
Copyright Clearance Center
MAY 15, 2024
The post The Interplay Between Copyright Licensing and Exclusive Rights; AI Edition appeared first on Copyright Clearance Center.
Pharmaceutical Technology
MAY 15, 2024
Nabla Bio has secured $26m in a Series A financing round led by Radical Ventures, for generative protein designing.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
PharmaTimes
MAY 15, 2024
The condition is the ninth most common cancer in the UK and affects 12,300 people annually
Eversana Intouch
MAY 15, 2024
Reddit, on its way to becoming the third most visited global website, has formed a symbiotic relationship with Google, highlighting its growing digital importance. This presents a golden opportunity for pharma brands to utilize community-driven platforms like Reddit. Thanks to its recent Google partnership and exponential YoY growth in search appearances, Reddit is emerging as a key hub for genuine engagement and peer insights.
pharmaphorum
MAY 15, 2024
New biotech startup Uniquity Bio emerges with $300m in funding from Blackstone and a clinical-stage asthma and COPD drug licensed from MSD
Pharmaceutical Technology
MAY 15, 2024
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of incretin mimetic medicines for the treatment of Type 2 diabetes and obesity.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Copyright Clearance Center
MAY 15, 2024
During a time of thorough transformation towards Open Access and, moreover, Open Science, the field of scholarly communications is facing new challenges. Some of the challenges are related to an aging and somewhat antiquated infrastructure, and others are related to new technologies and the evolving landscape of scientific dissemination, where the disclosure of data is becoming central to and an essential part of research and reproducibility.
Pharmaceutical Technology
MAY 15, 2024
Miricorilant is a small molecule commercialized by Corcept Therapeutics, with a leading Phase II program in Obesity.
Quantified
MAY 15, 2024
The LTEN Conference is the premier gathering for professionals in the life sciences training field, and 2024 promises to be the best year yet. Whether you’re a seasoned educator, a training leader, or just stepping into the world of life sciences, this event offers tons of enriching experiences. Here are seven must-do activities to ensure a great experience at the conference. 1.
Evolve Your Success
MAY 15, 2024
A Mother’s Day special! Join us as we sit down with Sydney Selby , the innovative Vice President of Sales, Marketing, and Medical Education at Renata Medical , during a week when we honor mothers and the gifts they bring into our lives. Sydney illuminates the often-invisible struggles within pediatric congenital heart disease treatment, revealing how Renata Medical’s Minima Renata stent system is revolutionizing care for the tiniest hearts.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Expert insights. Personalized for you.
256 
Let's personalize your content